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Antimicrobial Peptides Human b-Defensins Stimulate
Epidermal Keratinocyte Migration, Proliferation
and Production of Proinflammatory Cytokines and
Chemokines
Franc¸ois Niyonsaba1, Hiroko Ushio1, Nobuhiro Nakano1, William Ng1,2, Koji Sayama3, Koji Hashimoto3,
Isao Nagaoka4, Ko Okumura5 and Hideoki Ogawa1
Besides their microbicidal functions, human b-defensins (hBD) and LL-37 activate different immune and
inflammatory cells, and their expression is enhanced in inflamed skin and cutaneous wound sites. To protect
against pathogens, the skin produces antimicrobial peptides including hBDs and LL-37. Therefore, the aim of
our study was to investigate whether hBDs participate in cutaneous inflammation and wound healing by
inducing keratinocyte migration, proliferation, and production of proinflammatory cytokines/chemokines. We
found that hBD-2, -3, and -4 but not hBD-1 stimulated human keratinocytes to increase their gene expression
and protein production of IL-6, IL-10, IP-10, monocyte chemoattractant protein-1, macrophage inflammatory
protein-3a, and RANTES. This stimulatory effect was markedly suppressed by pertussis toxin and U-73122,
inhibitors for G protein and phospholipase C, respectively. We also demonstrated that hBDs elicited
intracellular Ca2þ mobilization, and increased keratinocyte migration, and proliferation. In addition, these
peptides induced phosphorylation of EGFR, signal transducer and activator of transcription (STAT)1, and STAT3,
which are intracellular signaling molecules involved in keratinocyte migration and proliferation. In our study,
inhibition of these molecules significantly reduced hBD-mediated keratinocyte migration and proliferation. In
conclusion, this study provides evidence that human antimicrobial peptides may be involved in skin immunity
through stimulating cytokine/chemokine production, and participate in wound healing by promoting
keratinocyte migration and proliferation.
Journal of Investigative Dermatology (2007) 127, 594–604. doi:10.1038/sj.jid.5700599; published online 19 October 2006
INTRODUCTION
The skin generates a number of antimicrobial peptides that
form part of innate immunity of the epithelial barrier. The
major antimicrobial peptides found in humans are defensins
and cathelicidins, which inactivate and kill invading micro-
organisms (Lehrer and Ganz, 1999). Defensins are characte-
rized by six cysteine residues forming three intramolecular
disulfide bridges, and are divided into the a- and b-defensins
based on the distribution of the cysteines and linkages of the
disulfide bonds. Six human a-defensins have been identified;
four of them named human neutrophil peptides 1–4 are
generated by neutrophils, and the other two termed human
defensins-5 and -6 are produced and stored in the secretory
granules of intestinal Paneth cells (Oppenheim et al., 2003).
In contrast to a-defensins, human b-defensins (hBD) are
mainly generated by epithelial tissues including skin and
respiratory tract. So far, four hBDs namely, hBD-1, -2, -3, and
-4 have been identified in human skin (Fulton et al., 1997;
Harder et al., 1997, 2001, 2004; Ali et al., 2001; Oppenheim
et al., 2003). hBD-1 is constitutively produced by various
epithelial tissues, its expression is especially prominent
in terminal layers of the skin (Fulton et al., 1997; Ali et al.,
2001), and may be induced by lipopolysaccharide and
peptidoglycan in keratinocytes (Sørensen et al., 2005).
hBD-2 was originally isolated from extracts of lesional scales
from psoriatic skin, and is inducible in inflamed skin lesions
upon treatment with lipopolysaccharide, tumor necrosis
factor-a, IL-1b, and bacteria (Harder et al., 1997; Liu et al.,
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2002). hBD-2 is localized to the uppermost layers of the
epidermis (Huh et al., 2002; Oren et al., 2003), and the levels
of hBD-2 dramatically increase in differentiated keratinocytes
(Harder et al., 2004). Furthermore, it has been demonstrated
that hBD-2 is synthesized and stored in lamellar bodies of
keratinocytes of the spinous and granular layers (Huh et al.,
2002; Oren et al., 2003). hBD-3 was detected by screening
human genomic sequences (Garcı´a et al., 2001a; Jia et al.,
2001), and successively isolated from human lesional
psoriatic scales (Harder et al., 2001). This peptide has been
found in both epithelial and non-epithelial tissues (Garcı´a
et al., 2001a). The expression of hBD-3 is upregulated in
keratinocytes and epithelia of the respiratory, gastrointestinal,
and genito-urinary tracts upon stimulation by tumor
necrosis factor-a, IL-1b, IFN-g, and bacteria (Harder et al.,
2001; Garcı´a et al., 2001a). The fourth member of hBDs,
hBD-4, was initially identified by screening the human
genome database (Garcı´a et al., 2001b). It is upregulated
by infection with bacteria and phorbol 12-myristate 13-
acetate in epithelial cells (Garcı´a et al., 2001b). The gene
expression of hBD-4 is inducible in primary keratinocytes
(Harder et al., 2004).
In addition to hBDs, the skin epithelium also generates
cathelicidins, which are a family of antimicrobial peptides
containing a highly conserved N-terminal cathelin domain
and a C-terminal cationic antimicrobial domain that becomes
active after cleavage (Zanetti et al., 1995). Although many
cathelicidin members have been identified in mammalians,
only one cathelicidin LL-37 is present in humans. LL-37 was
identified in myeloid cells, and later shown to be expressed in
various epithelia and particularly in keratinocytes of inflamed
skin (Sørensen et al., 1997, Frohm et al., 1999).
Apart from their direct microbicidal functions, antimicro-
bial peptides are known to activate several types of human
cells. hBD stimulate the degranulation of mast cells
(Befus et al., 1999) and chemoattract monocytes, and T cells
(Chertov et al., 1996). Furthermore, hBDs and LL-37 are
chemotaxins for immune and inflammatory cells (Yang et al.,
1999, 2000; Niyonsaba et al., 2002a, b, 2004). In addition,
these peptides are involved in the production of proinflam-
matory mediators such as histamine and prostaglandin
D2 from mast cells (Niyonsaba et al., 2001), and IL-18 by
keratinocytes (Niyonsaba et al., 2005).
The ability of the skin to protect against pathogens has
been in part attributed to the presence of antimicrobial agents
such as hBDs and LL-37 that have been shown to play major
roles in the innate immune system. Moreover, the expression
of LL-37 has been demonstrated to be enhanced in wounds
(Dorschner et al., 2001), and a-defensins as well as LL-37
have been reported to be involved in cell proliferation and
wound closure in airway epithelium (Aarbiou et al., 2002,
2004; Shaykhiev et al., 2005). The wound closure process is
initiated by a series of cellular activities such as cell
migration, proliferation, and differentiation (Zahm et al.,
2000). It was the aim of the current study to characterize the
roles of hBDs in activation of keratinocytes and induction of
cell migration and proliferation. We found that hBD-2, -3,
and -4 but not hBD-1 stimulated gene expression and
production of various proinflammatory cytokines and
chemokines by human primary keratinocytes. Moreover,
the production of these cytokines/chemokines was mediated
through the G protein and phospholipase C (PLC) signaling
pathway. In addition, we revealed that hBDs increased the
migration and proliferation of keratinocytes mediated by
EGFR, signal transducer and activator of transcription
(STAT)1 and STAT3, molecules involved in keratinocyte
migration and proliferation (Sano et al., 1999). Furthermore,
hBDs were also able to induce phosphorylation of EGFR,
STAT1, and STAT3.
RESULTS
hBDs increase the gene expression of proinflammatory cyto-
kines and chemokines
To investigate the effects of human antimicrobial peptides in
the skin, we first analyzed whether hBDs could induce the
messenger RNA (mRNA) expression of various proinflamma-
tory cytokines and chemokines from keratinocytes. Human
primary keratinocytes were incubated with 30 mg/ml of hBD-
1, -2, -3, and -4 for 1–24 hours, and gene expression was
analyzed using real-time PCR. Among the cytokines and
chemokines investigated, we revealed that hBD-2, -3, and -4
significantly induced the mRNA expression of IL-6, IL-10,
IFN-g-inducible protein (IP-10), monocyte chemoattractant
protein-1, macrophage inflammatory protein-3a, and regu-
lated upon activation, normal T cell expressed and secreted
(RANTES) (Figure 1). The increase of mRNA expression was
observed from 2 to 6 hours before decreasing gradually.
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Figure 1. hBDs increase the gene expression of proinflammatory cytokines
and chemokines in keratinocytes. Normal human keratinocytes were
incubated with 30mg/ml of hBD-1, -2, -3, -4, and LL-37 or medium alone for
6 hours. Following the incubation, total RNA was extracted, converted into
cDNA, and real-time PCR was performed to analyze the changes in gene
expression. Each bar shows the mean7SD from five separate experiments,
each experiment run in triplicate. Values represent fold-increases in gene
expression above cells incubated with medium alone (Med). *Po0.01,
**Po0.001.
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Figure 1 shows the data of a 6 hour-stimulation. In contrast to
hBD-2, -3, and -4, hBD-1 did not increase the gene
expression of above cytokines and chemokines, even at
higher concentrations (data not shown). We used 30 mg/ml of
each peptide because in preliminary dose-dependent experi-
ments, this concentration induced the maximal mRNA levels
of cytokines and chemokines without causing cytotoxicity, as
verified by trypan blue exclusion, lactate dehydrogenase
(LDH) activity, and cytotoxicity assay using cell-counting kit-8
(CCK-8, data not shown). We also confirmed that another
keratinocyte-derived antimicrobial peptide LL-37 significantly
induced gene expression of investigated cytokines and
chemokines in a similar manner to that seen with hBDs.
hBD-2, -3, and -4 induce the production of cytokines and
chemokines by keratinocytes
Because hBDs increase the gene expression of proinflamma-
tory cytokines and chemokines, we postulated that these
peptides could also stimulate keratinocytes to produce their
respective proteins. After stimulation of keratinocytes with
hBDs (30 mg/ml each) for 48 hours, the production of
cytokines and chemokines in cell-free supernatants was
determined by appropriate ELISA kits. As shown in Figure 2,
hBD-2, -3, and -4 induced the production of IL-6, IL-10, IP-10,
monocyte chemoattractant protein-1, macrophage inflam-
matory protein-3a, and RANTES. The cytokine and chemo-
kine production was also dose dependently detectable after
stimulation with concentrations of hBDs lower than 30 mg/ml
(data not shown). As expected, the effect of hBD-1 on
cytokine and chemokine production was not observed. In this
respect, hBD-1 used was biologically active because the
same reagent has been shown to effectively kill E. coli and
Staphylococcus aureus (Chen et al., 2005). In addition to
hBDs, we observed that LL-37 also significantly induced the
production of keratinocyte cytokines and chemokines in the
same range as hBDs.
Effects of pertussis toxin and U-73122 on hBD-mediated
cytokine and chemokine production
It has been reported that hBD-2 chemoattracts T cells and
dendritic cells through a G protein receptor CCR6 (Yang
et al., 1999) and activates mast cells via unidentified G
protein receptors coupled to PLC (Niyonsaba et al., 2001).
Thus, to seek whether hBDs activate keratinocytes through G
protein- and PLC-mediated signaling pathway, cells were
pretreated for 2 hours with 200 ng/ml pertussis toxin (PTx),
10 mM U-73122, or the inactive analog of U-73122, U-73343
before stimulation with 30 mg/ml hBD-1, -2, -3, and -4. PTx
and U-73122 pretreatment decreased the stimulatory effects
of hBD-2, -3, and -4, as well as LL-37 to elicit the production
of IL-6 and IP-10 (Figure 3a and b). Similar results were
obtained for IL-10, monocyte chemoattractant protein-1,
macrophage inflammatory protein-3a, and RANTES produc-
tion (data not shown). U-73343 used at the same concentra-
tion as U-73122 did not affect hBD- and LL-37-mediated
cytokine and chemokine production, demonstrating that the
effect of U-73122 was specific. Thus, G protein – PLC
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Figure 2. hBDs induce the production of cytokines and chemokines from
keratinocytes. Keratinocytes were stimulated with 30 mg/ml of hBD-1, -2, -3,
-4, and LL-37 for 48 hours, and the concentrations of different cytokines and
chemokines released into the culture supernatants were determined by ELISA.
Values are compared between the stimulated and non-stimulated cells (Med:
medium alone). *Po0.05, **Po0.01. Each bar represents the mean7SD of
three to five independent experiments.
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Figure 3. Inhibitory effects of PTx, U-73122, and PLCb2 siRNA on hBD-
induced IL-6 and IP-10 production. (a and b) Keratinocytes were pretreated
with 200 ng/ml PTx (dots), 10 mM U-73122 (horizontal stripes), 10 mM U-73343
(diagonal stripes), or medium alone without inhibitors (open bars) for 2 hours.
Cells were then challenged for 48 hours with 30 mg/ml of hBD-1, -2, -3, -4,
and LL-37. The concentrations of released IL-6 (a) and IP-10 (b) into the
culture supernatants were measured by ELISA. *Po0.05. Values are the
mean7SD of three to five separate experiments, and compared between the
presence or absence of inhibitors. (c and d) Keratinocytes were transfected
with 100 nM PLCb2 siRNA (dots) or control-siRNA (horizontal stripes) for
24 hours, cultured overnight in a new medium without supplements, and then
stimulated with 30 mg/ml of hBD-1, -2, -3, -4, and LL-37 for 48 hours. ELISA
assay was performed as above. *Po0.05. Values are the mean7SD of four
separate experiments, and compared between the control cells (open bars) or
control-siRNA transfectants.
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signaling pathway is required for the activities of hBDs on
keratinocytes.
To further confirm the G protein – PLC pathway involve-
ment in hBD stimulatory effects, we attempted to inhibit the
downstream of this pathway through knockdown of PLCb2 by
transfecting keratinocytes with PLCb2 small-interfering RNA
(siRNA), because it has been demonstrated that U-73122
inhibits PLCb2 more potently than other PLCb isozymes (Hou
et al., 2004). Of interest, knockdown of PLCb2 was
associated with a significant reduction of IL-6 and IP-10
production, compared with control cells or control-siRNA
transfectants (Figure 3c and d). We further observed that
transfection of PLCb1 siRNA and PLCb3 siRNA into
keratinocytes also moderately reduced IL-6 and IP-10
production (data not shown).
hBDs elicit intracellular Ca2þ mobilization by keratinocytes
We next examined the ability of hBDs to mobilize
intracellular Ca2þ using Fura-2-AM-loaded keratinocytes.
In preliminary experiments, the results revealed a dose-
dependent stimulatory effect of hBDs, reaching the plateau at
30 mg/ml. As shown in Figure 4, stimulation of keratinocytes
with hBD-2, -3, and -4 markedly increased keratinocyte
intracellular Ca2þ concentration. However, cells challenged
with hBD-1 did not show any change in intracellular Ca2þ
concentration, which was similar to that induced by the
control (0.01% acetic acid used as diluent). In same
experimental conditions, LL-37 also markedly increased
keratinocyte intracellular Ca2þ concentration at same levels
seen with hBDs.
hBDs stimulate the migration of human keratinocytes
Because antimicrobial peptides including LL-37 have been
reported to mediate migration of airway epithelial cells
(Shaykhiev et al., 2005) and keratinocytes (Tokumaru et al.,
2005), we hypothesized that hBDs may also stimulate
keratinocyte migration. The chemotactic activities of hBDs
were analyzed using the Boyden chamber assay. When
various concentrations of hBDs (1–40 mg/ml) were added to
the lower chambers, keratinocytes into the upper chambers
significantly migrated towards hBD-2, -3, and -4, compared
to the medium alone. The migratory effect of these peptides
was bell-shaped, reaching a peak at 5 mg/ml for hBD-3 and
10 mg/ml for hBD-2 and hBD-4 (Figure 5b, c, and d). There
was no increase in migration of cells treated with hBD-1 at all
concentrations tested (Figure 5a), or another skin-derived
antimicrobial peptide named dermcidin (data not shown),
suggesting a specific effect of hBD-2, -3, and -4 on
keratinocyte migration. Transforming growth factor (TGF)-a,
a well-known keratinocyte chemoattractant was more potent
than hBDs (Figure 5e). We observed that a non-coated
membrane allowed a slight but significant migration of
keratinocytes towards hBDs, however, the migratory effect
was markedly enhanced in a collagen-coated membrane.
Moreover, there was no significant difference between data
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Figure 5. hBDs mediate keratinocyte migration (Boyden chamber assay).
The indicated doses (1–40mg/ml) of (a) hBD-1, (b) hBD -2, (c) hBD -3, and
(d) hBD-4 were added to the lower wells, and 5 103 cells/well were applied
into the upper chambers of 48-well chemotaxis microchamber. Following a
6-hour incubation, the membrane was stained and keratinocyte migration
was assessed by counting under a microscope the number of migrated cells
through the polycarbonate membrane in five randomly chosen high power
fields. Each bar shows the mean7SD of four to six separate experiments.
*Po0.05, **Po0.01 as compared between stimulated and non-stimulated
cells. (e) 40mg/ml hBD-1, 10 mg/ml hBD-2, 5 mg/ml hBD-3, 10 mg/ml hBD-4,
and 10 ng/ml TGF-a were used to induce keratinocyte migration as above.
**Po0.01, ***Po0.01 as compared between stimulated and non-stimulated
cells.
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obtained from collagen-, fibronectin-, or vitronectin-coated
membranes (data not shown). Thus, one could not exclude
haptotactic effect of collagen on hBD-mediated keratinocyte
migration.
The Boyden chamber assay data were further complimen-
ted by those of in vitro wound closure assay. As shown in
Figure 6, keratinocytes incubated with optimal doses of
hBD-2, -3, and -4 migrated inwardly and covered a greater
area of the wound, compared with hBD-1 or medium alone,
with TGF-a as a positive control.
hBDs increase keratinocyte proliferation
As LL-37 has been implicated in cell migration and
proliferation in epithelial cells, it is probable that hBDs might
induce keratinocyte proliferation in addition to migration.
Cell proliferation was evaluated by BrdU incorporation
complimented with cell count assay and CCK-8 assay.
Following a 48-hour incubation, keratinocytes stimulated
with 5–40 mg/ml of hBD-2, -3, and -4 dose dependently
increased keratinocyte labeling with BrdU (Figure 7b, c, and
d). The effect of hBD-1 on enhancing BrdU incorporation was
not observed. To confirm BrdU incorporation results, cells
were incubated with hBDs and counted over 24 and
48 hours. As shown in Figure 7e, markedly increased cell
numbers were observed after stimulation with hBD-2, -3, and
-4. Similarly, the CCK-8 assay demonstrated that hBD-2, -3,
and -4 enhanced keratinocyte proliferation (Figure 7f).
hBDs induce phosphorylation of EGFR, STAT1, and STAT3
It has been shown that EGFR mediates the migration of
keratinocytes, and its activation induces the phosphorylation
of both STAT1 and STAT3, which also participate in
keratinocyte migration and proliferation (Sano et al., 1999;
Kijima et al., 2002; Andl et al., 2004). Furthermore, LL-37 has
been recently shown to induce phosphorylation of EGFR and
STAT3 (Tokumaru et al., 2005). Thus, we envisaged that
hBDs could activate EGFR, STAT1, and STAT3. Following
stimulation of keratinocytes with hBDs, the phosphorylation
Medium hBD-1
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Figure 6. hBDs mediate keratinocyte migration (in vitro wound closure
assay). A cell-free zone was made in confluent cultures of keratinocytes as
described in Materials and Methods. The cells were incubated for 6 hours
with 40 mg/ml hBD-1, 10mg/ml hBD-2, 5 mg/ml hBD-3, 10mg/ml hBD-4, and
10 ng/ml TGF-a or medium alone (medium) in the presence of mitomycin C.
Live cultures were photographed under phase-contrast microscopy. Data
shown are representative of three independent experiments. Bar¼200 mm.
Br
dU
 in
co
rp
or
a
tio
n 
(%
)
Br
dU
 in
co
rp
or
a
tio
n 
(%
)
Br
dU
 in
co
rp
or
a
tio
n 
(%
)
Br
dU
 in
co
rp
or
a
tio
n 
(%
)
0
5
10
20
15
40
30
20
10
0
60
50
50
40
30
20
10
0
40
30
20
10
0
4
3
2
1
0
7.5
5.0
2.5
0.0
0 5 10 20 40
hBD-1 (g/ml)
0 5 10 20 40
hBD-3 (g/ml)
0 5 10 20 40
hBD-2 (g/ml)
0 5 10 20 40
hBD-4 (g/ml)
Ce
ll n
u
m
be
r (
10
5 )
Ab
so
rb
an
ce
TG
F-
hB
D-
1
Me
d
hB
D-
2
hB
D-
3
hB
D-
4
TG
F-
hB
D-
1
Me
d
hB
D-
2
hB
D-
3
hB
D-
4
a b
c d
e f
*
*
*
*
**
**
*
**
*
* * *
**
**
**
**
**
**
**
**
Figure 7. hBDs stimulate human keratinocyte proliferation. Keratinocytes
(1104 cells/ml) were cultured on Lab-Tek II eight-chamber glass slides, and
subconfluent cells were incubated with 5–40mg/ml of (a) hBD-1, (b) hBD -2,
(c) hBD -3, and (d) hBD -4 or medium alone for 48 hours. After incubation
with 10 mM BrdU for 1 hour, the numbers of BrdU-positive cells were counted
under a light microscope. Data are expressed as a percentage of the
BrdU-positive cells (BrdU incorporation). Values are the mean7SD of five
independent experiments. *Po0.05, **Po0.01 as compared between
stimulated and non-stimulated cells. (e) Keratinocytes (1 105 cells/ml) were
cultured in 12-well plate for 24 hours, followed by stimulation with 40 mg/ml
hBD-1, 40 mg/ml hBD-2, 20mg/ml hBD-3, 40 mg/ml hBD-4, or 100 ng/ml
TGF-a for 24 hours (dots) or 48 hours (open bars). Cells were then trypsinized
and counted under a light microscope. Values are the mean7SD of five
separate experiments. *Po0.05, **Po0.01 as compared between stimulated
and non-stimulated cells. (f) Keratinocytes (5 103 cells/well) were cultured
in a 96-well plate and stimulated with 40 mg/ml hBD-1, 40mg/ml hBD-2,
20mg/ml hBD-3, 40mg/ml hBD-4, or 100 ng/ml TGF-a for 48 hours. Cells were
treated with 10ml CCK-8 solution/well and incubated for 3 hours at 371C. The
amount of formazan dye was measured by absorbance at 450 nm with a
microplate reader. *Po0.05, **Po0.01 as compared between stimulated and
non-stimulated cells.
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of EGFR, STAT1, and STAT3 was analyzed by Western
blotting. As observed in Figure 8, hBD-2, -3, and -4 but not
hBD-1 induced phosphorylation of EGFR and STAT1 at 10
and 20 minutes, and STAT3 at 20 and 30 minutes. The
phosphorylation was quantified by densitometry and shown
on right panels of Figure 8.
Activation of EGFR, STAT1, and STAT3 is necessary for hBD-
mediated keratinocyte migration and proliferation
To determine whether hBD-mediated EGFR, STAT1, and
STAT3 phosphorylation was required for keratinocyte migra-
tion and proliferation, cells were pretreated with 20 mg/ml of
anti-EGFR antibody, 50 nM of EGFR inhibitor AG 1478, or
100mM of STAT1 inhibitor fludarabine (Frank et al., 1999),
and keratinocyte migration and proliferation assays were
subsequently performed as described in Materials and
methods. Figure 9 shows that anti-EGFR antibody, AG 1478
and fludarabine markedly reduced hBD-mediated keratino-
cyte migration (Figure 9a) and proliferation (Figure 9b).
Similar effect was observed in LL-37-stimulated keratino-
cytes. The control IgG antibody did not affect keratinocyte
migration and proliferation.
Next, to analyze the role of STAT3 in hBD-induced
keratinocyte migration and proliferation, adenovirus-carrying
STAT3 dominant-negative mutant (AxCASTAT3F) and the
control vector AxLacZ were generated and transfected into
keratinocytes (Tokumaru et al., 2005), and cell migration or
proliferation was subsequently analyzed. We found that
STAT3 dominant-negative significantly suppressed hBD-
induced keratinocyte migration and proliferation (Figure
10a and b). Together, these observations imply that the
activation of EGFR, STAT1, or STAT3 is required for hBD-
mediated human keratinocyte migration and proliferation.
DISCUSSION
The current study demonstrates that endogenous human
antimicrobial peptides hBDs stimulate keratinocytes to
produce proinflammatory cytokines and chemokines, the
production of which is through the G protein and PLC
signaling pathway. Furthermore, these peptides mediate
keratinocyte migration and proliferation under the control
of EGFR, STAT1, and STAT3 activation.
Upon stimulation by antimicrobial peptides, different
immune and inflammatory cells have been shown to produce
cytokines and/or chemokines. For instance, human neutro-
phil peptides-1 and -3 stimulate the production of IL-1, -4, -6,
tumor necrosis factor-a, and IFN-g in monocytes (Chaly et al.,
2000), and chemokines monocyte chemoattractant protein-1
and macrophage inflammatory protein-2 in lung epithelial
cells (Zhang et al., 2001). Moreover, hBDs and LL-37 have
been recently reported to enhance the generation of IL-18 in
keratinocytes (Niyonsaba et al., 2005). Here we show that
R
at
io
 (p
-E
GF
R/
tE
GF
R) 2.0
1.5
1.0
0.5
0.0
10 minutes
10 minutes
20 minutes
30 minutes
10 minutes
20 minutes
30 minutes
10 minutes
20 minutes
30 minutes
20 minutes 30 minutes
10 minutes 20 minutes 30 minutes
10 minutes 20 minutes 30 minutes
2.0
1.0
0.5
0.0
1.5
2.0
1.0
0.5
0.0
1.5
R
at
io
 (p
-S
TA
T1
/tS
TA
T1
)
R
at
io
 (p
-S
TA
T3
/tS
TA
T3
)
1 2 3 4 5 6
p-EGFR
p-STAT1
tSTAT1
p-STAT1
tSTAT1
p-STAT1
tSTAT1
p-STAT3
tSTAT3
p-STAT3
tSTAT3
p-STAT3
tSTAT3
tEGFR
p-EGFR
tEGFR
p-EGFR
tEGFR
*
*
*
*
*
*
* *
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
* *
*
*
*
*
Figure 8. hBDs induce phosphorylation of EGFR, STAT1, and STAT3. Keratinocytes were stimulated with 30 mg/ml of hBD-1, -2, -3, -4, or 5mg/ml of LL-37 for
10, 20, or 30 minutes, and phosphorylated EGFR (p-EGFR), STAT1 (p-STAT1), or STAT3 (p-STAT3) and total EGFR (tEGFR), STAT1 (tSTAT1), or STAT3 (tSTAT3)
levels in cell lysates were determined by Western blot analysis. Lane 1: medium alone, Line 2: hBD-1, Lane 3: hBD-2, Lane 4: hBD-3, Line 5: hBD-4, Line 6:
LL-37. Shown is one representative of five independent experiments with similar results. Right panels: Bands were quantified by densitometry using the software
program Image Gauge (LAS-1000plus) to allow correction for protein loading. Data represent the ratio of the intensity of phosphorylated protein (p-EGFR,
p-STAT1, or p-STAT3) divided by total protein (tEGFR, tSTAT1, or tSTAT3). Values are the mean7SD of five independent experiments. *Po0.05 as compared
between stimulated and non-stimulated cells.
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hBDs stimulated both the gene and protein expression of
various cytokines and chemokines such as IL-6, -10, and
IP-10, monocyte chemoattractant protein-1, macrophage
inflammatory protein-3a, and RANTES in keratinocytes. In
addition, we confirmed that LL-37 had similar stimulatory
effects on keratinocytes as seen with hBDs. Therefore, the
ability of hBDs and LL-37 to induce the production of
proinflammatory cytokines and chemokines suggests the
broad role of human antimicrobial peptides in primary
immune responses of epidermal cells.
The cytokine and chemokine producing activities of hBDs
involved the G protein- and PLC-dependent pathway, as
demonstrated by the inhibitory effects of PTx and U-73122
against hBDs, and confirmed by the reduction of cytokine
and chemokine production following PLCb knockdown.
Because PTx inhibits Gi/oa proteins (Clapham, 1995), and
as bg subunits of G proteins dissociated from Gi/oa regulate
PLCb activities (Kehrl, 1998; Knall and Johnson, 1998), it is
possible that Gi/oa coupled to PLCb participate in hBD-
mediated activation of keratinocytes. Although antimicrobial
peptides including hBDs and LL-37 have been shown to
function via G protein-coupled receptors, their specific
receptors are not yet well known. In our unpublished data,
we observed that no cross-desensitization of intracellular
Ca2þ transients between hBD-1, -2, -3, -4, and LL-37 was
detected. Thus, this observation suggests that hBDs and LL-37
act on their target cells through distinct receptors. Further
studies will be necessary to identify their functional receptors
on keratinocytes.
A multilayered epidermis composed of keratinocytes
separates the inner body from the outer environment and
protects against microbial pathogens. Hence, keratinocytes
are important components of innate immunity, particularly
during the wound closure process. In the skin, bacteria and
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Figure 9. Inhibition of hBD-mediated keratinocyte migration and prolifera-
tion by anti-EGFR antibody, AG 1478, and fludarabine. (a) 40mg/ml hBD-1,
10mg/ml hBD-2, 5 mg/ml hBD-3, 10mg/ml hBD-4, and 5 mg/ml LL-37 were
added to the lower chambers together with 20 mg/ml anti-EGFR antibody
(dots), 50 nM AG 1478 (horizontal stripes), 100 mM fludarabine (diagonal
stripes), 20 mg/ml control IgG antibody (zigzag lines), or medium alone
without inhibitors (open bars) for 6 hours, and the keratinocyte migration was
analyzed as described in Figure 5. (b) Keratinocytes were pretreated with
20mg/ml anti-EGFR antibody (dots), 50 nM AG 1478 (horizontal stripes),
100mM fludarabine (diagonal stripes), 20 mg/ml control IgG antibody (zigzag
lines), or medium alone (open bars) for 2 hours, and then stimulated with
40mg/ml hBD-1, 40 mg/ml hBD-2, 20 mg/ml hBD-3, 40mg/ml hBD-4, or
20mg/ml LL-37. Cell proliferation assay was performed as described in
Figure 6. *Po0.05 as compared between the presence and absence of
inhibitors or antibodies. Values are the mean7SD of four to six separate
experiments.
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Figure 10. Inhibition of hBD-induced keratinocyte migration and prolifera-
tion by STAT3F. (a) Keratinocytes were infected with adenoviruses carrying
LacZ (AxLacZ) (open bars) or STAT3F (AxCASTAT3F) (dots) at a multiplicity of
infection of 1 102 plaque-forming units per cell in 1 ml for 24 hours. Cells
were then detached, resuspended in culture medium and applied into the
upper wells of 48-well chemotaxis microchamber. Thereafter, 40 mg/ml hBD-
1, 10 mg/ml hBD-2, 5 mg/ml hBD-3, 10 mg/ml hBD-4, and 5 mg/ml LL-37 were
added to the lower chambers. Cell migration was analyzed as described in
Materials and Methods section. (b) Keratinocytes cultured on Lab-Tek II eight-
chamber glass slides were infected with AxLacZ (open bars) or AxCASTAT3F
(dots) at a multiplicity of infection of 1 102 plaque-forming units per cell in
1 ml for 24 hours. Cells were then incubated with 40 mg/ml hBD-1, 40mg/ml
hBD-2, 20mg/ml hBD-3, 40 mg/ml hBD-4, and 20 mg/ml LL-37 for 48 hours at
371C. Cell proliferation assay was performed as described in Materials and
Methods. *Po0.05 as compared between AxLacZ- and AxCASTAT3F-
infected cells. Values are the mean7SD of four separate experiments.
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inflammatory factors as well as wounding are reported to
stimulate the production of hBDs by keratinocytes. As the
expression of antimicrobial peptides is upregulated at the skin
wound site (Dorschner et al., 2001), the current study
suggests that hBDs may participate in cutaneous wound
closure through their induction of keratinocyte migration and
proliferation. The stimulatory effects of hBDs on keratinocyte
motility were less strong than those of TGF-a, which is known
to induce both keratinocyte migration and proliferation (Cha
et al., 1996). Because EGFR, STAT1, and STAT3 are
implicated in keratinocyte migration and proliferation (Sano
et al., 1999), the effects of hBDs on these molecules were
studied. The data demonstrated that hBDs induced phosphor-
ylation of EGFR, STAT1, and STAT3, and that the inhibition of
these molecules resulted in suppression of keratinocyte
migration and proliferation. Other antimicrobial peptides
including a-defensins have been demonstrated to induce the
lung epithelial cell proliferation and wound closure (Aarbiou
et al., 2002, 2004), and also LL-37 plays a key role in repair
of damaged tissue and wound healing by promoting wound
neovascularization and re-epithelialization (Heilborn et al.,
2003; Koczulla et al., 2003). Thus, human antimicrobial
peptides may share properties in activating epithelial
surfaces.
Although the concentrations of antimicrobial peptides in
human body are not precisely known, it has been proven that
the epithelial tissues contain high concentrations of hBDs and
LL-37, particularly at sites of infection or inflammation. For
example, hBD-2 and LL-37 have been respectively estimated
at B157 mM and X1,605 mM in psoriatic skin lesions (Ong
et al., 2002). This shows that the doses of hBDs and LL-37
(ranging from 1 to 40 mg/ml, equivalent to 0.2 to 10mM) we
used in the current report may be adequate for evaluating the
physiological roles of hBDs and LL-37 in keratinocytes.
In summary, hBDs induce human keratinocyte migration,
proliferation and production of proinflammatory cytokines,
and chemokines. Our finding provides evidence that
epithelial cell-derived antimicrobial peptides are involved
in skin immunity through their activity on keratinocyte
production of cytokines and chemokines, migration, and
proliferation.
MATERIALS AND METHODS
Reagents
Synthetic hBD-1, hBD-2, hBD-3, and hBD-4 were purchased from
Peptide Institute (Osaka, Japan). LL-37 (L1LGDFFRKSKEKIGKEFK-
RIVQRIKDFLRNLVPRTES37) was synthesized by the solid-phase
method on a peptide synthesizer (model PSSM-8, Shimadzu, Kyoto,
Japan). U-73122 (1-[6-([(17b)-3-methoxyestra-1, 3, 5 (10)-trien-17-
yl] amino) hexyl]-1H- pyrrole-2.5-dione), U-73343 (1-[6-[(17b)-3-
methoxyestra-1, 3, 5 (10)-trien-17-yl] amino] hexyl)-2,5-pyrrolidi-
nedione), PTx, TGF-a, and mitomycin C were purchased from Sigma
(St Louis, MO). Fura-2 acetoxy-methylester (Fura-2-AM) was
obtained from Dojindo Laboratories (Kumamoto, Japan). Rabbit
polyclonal anti-phosphorylated EGFR, STAT1, and STAT3 antibodies
and total EGFR, STAT1, and STAT3 antibodies were from Cell
Signaling Technology (Beverly, MA). EGFR neutralizing antibody
(clone 225) and AG 1478 were purchased from Calbiochem
(La Jolla, CA), and fludarabine was from Toronto Research
Chemicals (Ontario, Canada).
Keratinocyte culture and stimulation
Normal human epidermal keratinocytes purchased from Kurabo
Industries (Osaka, Japan) were cultured in serum-free keratinocyte
growth medium, HuMedia-KG2 (Kurabo Industries) containing
human epidermal growth factor (0.1 ng/ml), insulin (10 mg/ml),
hydrocortisone (0.5mg/ml), gentamycin (50 mg/ml), amphotericin B
(50 ng/ml), and bovine brain pituitary extract (0.4% vol/vol), as
reported previously (Niyonsaba et al., 2005). After cells were serially
passaged at 60–70% confluence, experiments were conducted with
subconfluent cells at passage three or four in the proliferative phase
at 60–80% confluence. For stimulation, keratinocytes were cultured
in 12-well tissue culture plates, and for total RNA extraction and
Western blot, cells were cultured in six-well plates. After removal of
growth medium, cells were washed twice with phosphate-buffered
saline (PBS) () before culture in HuMedia supplemented with only
antibiotics for 24 hours. The keratinocytes were subsequently
stimulated with hBD-1, -2, -3, and -4 or LL-37 at indicated periods.
In some experiments, keratinocytes were pretreated with 200 ng/ml
PTx, 10 mM U-73122, or 10 mM U-73343 for 2 hours before
stimulation with various peptides.
To quantify the possible cytotoxicity of antibacterial peptides to
keratinocytes, LDH activity in the culture supernatants after
stimulation was measured using Cytotoxicity Detection Kit – LDH
(Roche Diagnostics, Indianapolis, IN) according to the manufac-
turer’s instructions. Percentage of LDH activity in the supernatants
was calculated as: ((experimental value–LDH activity released from
untreated cells)/(maximum releasable LDH activity in the cells by
1% Triton X-100LDH activity released from untreated
cells)) 100. Cytotoxicity was also assayed using CCK-8 (Dojindo).
Briefly, cells were cultured in a 96-well plate and stimulated with
various peptides for 1–48 hours. Cells were then treated with 10 ml
CCK-8 solution/well and incubated for 3 hours at 371C. The amount
of formazan dye generated by cellular dehydrogenase activity was
measured by absorbance at 450 nm with a microplate reader. Also,
trypan blue exclusion was used to determine the cytotoxicity of
peptides.
Adenovirus vectors
Dominant-negative mutants of STAT3 (STAT3F) were prepared by
substitution of tyrosine 705 with phenylalanine (Tokumaru et al.,
2005). Adenovirus vectors encoding STAT3F (AxCASTAT3F) and
LacZ (AxLacZ) were generated, purified, and transfected as
described previously (Tokumaru et al., 2005). Keratinocytes were
infected with adenovirus vectors at a multiplicity of infection of
1 102 plaque-forming units per cell in 1 ml of keratinocyte growth
medium for 24 hours, and thereafter tested for migration and
proliferation.
Total RNA extraction and real-time quantitative PCR
Total RNA was extracted from keratinocytes using Trizol reagent
(BRL, Life Technologies, Rockville, MD), according to the manu-
facturer’s instructions. First-strand cDNA was synthesized from 3mg
of total RNA with oligo(dT)12-18 primers using Superscript II RNase
H reverse transcriptase (Life Technologies), as described before
(Niyonsaba et al., 2005). Real-time PCR was performed using the
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TaqMan Universal PCR Master Mix (Applied Biosystems, Branch-
burg, NJ). Amplification and detection of mRNA were analyzed by
7500 real-time PCR System (Applied Biosystems), according to the
manufacturer’s specifications. All primer/probe sets used in this
study were obtained from Applied Biosystems assays on demand. To
standardize mRNA concentrations, transcript levels of the house-
keeping gene glyceraldehyde-3-phosphate dehydrogenase were
determined in parallel for each sample, and relative transcript levels
were corrected by normalization based on the glyceraldehyde-3-
phosphate dehydrogenase transcript levels. All real-time PCRs were
performed in triplicate, and the changes in gene expression were
reported as fold-increases relative to untreated controls.
RNA interference
The siRNA duplexes targeting PLC-b1, PLC-b2, and PLC-b3 were
purchased from Dharmacon (Chicago, IL). Keratinocytes were plated
at a density of 1 105 cells/well in six-well plates. Cells were
transfected with 100 nM of PLC-b1 siRNA, PLC-b2 siRNA, PLC-b3
siRNA, or control-siRNA as a control using DharmaFECT 1
(Dharmacon) according to the manufacturer’s specifications. Gene
silencing was conducted for 24 hours, and the efficacy of knock-
down was confirmed by real-time PCR analysis. Cells were further
cultured overnight in HuMedia without supplements, and subse-
quently stimulated with various peptides.
ELISA
Cytokines and chemokines released in the cell-free supernatants
from non-stimulated or stimulated cultures with 30mg/ml hBD-1, -2,
-3, -4, and LL-37 for 48 hours were measured with ELISA kits from
R&D Systems (Minneapolis, MN). Supernatants were stored at
201C until use for ELISA according to the manufacturer’s
instructions.
Measurement of intracellular Ca2þ concentration
Subconfluent keratinocytes were detached from culture plates using
0.025% trypsin and 0.25 mM EDTA, following two washes with PBS.
Cells were then washed twice with PBS containing 0.2% BSA, 0.1%
glucose, and 30 mM CaCl2, and resuspended in the same buffer at the
density of 2 106 cells/ml. After loading with 4mM Fura-2 AM for
1 hour at 371C, cells were washed three times, and then resuspended
in washing buffer at the concentration of 1 106 cells/ml for
stimulation. Fura-2-AM-loaded cells were stimulated with 30 mg/ml
hBD-1, -2, -3, -4, or LL-37, and fluorescence was measured at 340
and 380 nm excitation and 510 nm emission, using a Hitachi F-4500
spectrofluorometer (Hitachi, Tokyo, Japan).
Cell migration assays
Keratinocyte migration was assayed using a modified Boyden
chamber consisting of a 48-well microchamber (Neuro Probe,
Gaithersburg, MD). Various concentrations of peptides were added
to the lower wells, and an 8-mm pore-size polyvinylpyrrolidone-free
polycarbonate membrane (Neuro Probe, Gaithersburg, MD) was
placed between the lower wells and upper wells. The membrane
was pre-coated with 10 mg/ml type I collagen, 25 mg/ml fibronectin,
or 25 mg/ml vitronectin (Sigma) at 371C for 2 hours, and then washed
extensively with PBS. Shortly before the experiment, subconfluent
keratinocytes were trypsinized and resuspended in culture medium
containing antibiotics only at 1 105 cells/ml. A 50-ml aliquot of the
cell suspension (5 103 cells/well) was placed into the upper wells,
then the chamber was incubated for 6 hours at 371C in a humidified
atmosphere of air with 5% CO2. After incubation, cells adherent to
the upper surface of the filter membrane were removed by scraping
with a rubber blade. Cells that had migrated through the membrane
and adherent to the underside of the filter were fixed with 100%
methanol overnight. The filter was then stained with DiffQuick
(Kokusai Shiyaku, Kobe, Japan), mounted, and the cell migration was
quantified by counting under a light microscope. The results are
presented as migrated cell number/five high power fields chosen
randomly.
In some experiments, peptides were added to the lower chambers
together with PTx (200 ng/ml), U-73122 (10 mM), anti-EGFR antibody
(20 mg/ml), AG 1478 (50 nM), fludarabine (100 mM), or control IgG
antibody (20 mg/ml), and cell migration towards hBDs was deter-
mined as described above. Furthermore, to determine the role of
STAT3 in keratinocyte migration, AxCAStat3F, and AxLacZ were
transfected into keratinocytes at a multiplicity of infection of 1 102
for 24 hours followed by the migration assay.
A second migration assay, the in vitro wound closure assay,
was performed according to a modified procedure of Li et al.
(2004). Keratinocytes (1.5 105/well) were plated into 12-well
culture plate, and after 3 hours of incubation, the confluent
monolayer of cells was wounded with a p-200 pipette tip to create
a uniform cell-free zone in each well. Cellular debris were removed
by PBS washing. Wounded monolayers were then incubated for
6 hours in HuMedia without supplements, containing optimal doses
of hBDs. Mitomycin C (10 mg/ml) was always included in the
media to prevent cell proliferation. The repopulation of wounded
areas was observed under the phase-contrast microscope (Keyence,
Osaka, Japan).
Cell proliferation assay
Keratinocytes were cultured at a density of 1 104 cells/ml on Lab-
Tek II eight-chamber glass slides (Nalge Nunc International,
Naperville, IL). Subconfluent cells were incubated with various
peptides at indicated concentrations for 48 hours at 371C. Cell
proliferation was evaluated by a BrdU incorporation method using a
commercially available BrdU labeling and detection kit II (Roche
Diagnostics) according to the manufacturer’s instructions, by
incubating the peptide-stimulated cells with 10 mM BrdU for 1 hour
at 371C. The percentage of BrdU incorporation was calculated as
number of BrdU-positive cells/total number of cells 100.
Keratinocyte proliferation was further analyzed using CCK-8
according to manufacturer specifications as described above.
Moreover, 1 105 keratinocytes/well were cultured in 12-well plate
for 24 hours, and then stimulated for 24–48 hours with peptides
diluted in culture media without supplements. The media was then
removed, and cells were washed with PBS, trypsinized, and counted
under a light microscope.
The inhibition of keratinocyte proliferation was analyzed by
pretreating keratinocytes with PTx (200 ng/ml), U-73122 (10 mM),
anti-EGFR antibody (20 mg/ml), AG 1478 (50 nM), fludarabine
(100mM), or control IgG antibody (20 mg/ml) for 2 hours before
stimulation with peptides, and the proliferation assay was performed
as above by BrdU incorporation method. In parallel experiments,
keratinocytes were transfected with adenovirus vectors AxCAS-
TAT3F or AxLacZ followed by stimulation with peptides.
602 Journal of Investigative Dermatology (2007), Volume 127
F Niyonsaba et al.
Effects of hBDs on Human Keratinocytes
Western blot analysis
Subconfluent keratinocytes were stimulated with 30 mg/ml hBDs for
the indicated time periods. After stimulation, the lysates were
obtained by lysing cells in lysis buffer (50 mM Tris-HCl (pH 8),
150 mM NaCl, 0.02% NaN3, 0.1% SDS, 1% Nonidet P-40, contain-
ing 1mM phenylmethylsulphonyl fluoride, 10mg/ml leupeptin, 10mg/ml
pepstatin-A, 50 mg/ml aprotinin and 2 mM sodium orthovanadate).
The equal amounts of total protein were subjected to 15%
SDS-PAGE. After, nonspecific binding sites were blocked, and the
blots were incubated with polyclonal antibodies against phosphory-
lated EGFR, STAT1, and STAT3 or total EGFR, STAT1, and STAT3
overnight, according to the manufacturer’s instructions. The
membrane was developed with an enhanced chemiluminescence
detection kit (Amersham Pharmacia Biotech, Piscataway, NJ). To
quantify the intensity of bands, densitometry using the software
program Image Gauge (LAS-1000plus, Fujifilm, Tokyo, Japan) was
performed to allow correction for protein loading.
Statistical analysis
Statistical analysis was performed using Student’s t-test or one-way
analysis of variance, and Po0.05 was considered to be significant.
The results are shown as mean7standard deviation (SD).
All the above studies have Juntendo University institutional
approval and adherence to the Declaration of Helsinki Principles.
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